Apollo Endosurgery, Inc.

APEN · NASDAQ
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Activities
Net Income-$40-$25-$23-$27
Dep. & Amort.$3$3$4$4
Deferred Tax$0-$3$1$0
Stock-Based Comp.$7$6$2$1
Change in WC-$7$1-$8$1
Other Non-Cash$6$3$2-$4
Operating Cash Flow-$31-$14-$21-$26
Investing Activities
PP&E Inv.-$3-$1-$1-$1
Net Acquisitions$0$3$2$2
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$3$2$1$1
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$1$70$23$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$68$26$31
Financing Cash Flow$0$68$26$31
Forex Effect-$0-$0$0-$0
Net Chg. in Cash-$34$55$6$6
Supplemental Information
Beg. Cash$92$37$31$25
End Cash$58$92$37$31
Free Cash Flow-$34-$16-$21-$27
Apollo Endosurgery, Inc. (APEN) Financial Statements & Key Stats | AlphaPilot